SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Chemicals & Pharmaceuticals informs about Outcome of Board Meeting

15 Mar 2014 Evaluate

Orchid Chemicals & Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on March 14, 2014, has accepted the Letter of Approval (LOA) dated March 10, 2014 issued by Corporate Debt Restructuring Empowered Group (CDR EG) approving the Corporate Debt Restructuring proposal submitted by the Company. In this regard, the Company has submitted a copy of Press Release dated March 14, 2014 titled 'CDR Package Approval'.

The above information is a part of company’s filings submitted to BSE.

 

Orchid Pharma Share Price

981.90 -27.95 (-2.77%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: